[HTML][HTML] Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis
JL Jackson, A Kuriyama, Y Kuwatsuka, S Nickoloff… - PloS one, 2019 - journals.plos.org
Background Headaches are a common source of pain and suffering. The study's purpose
was to assess beta-blockers efficacy in preventing migraine and tension-type headache …
was to assess beta-blockers efficacy in preventing migraine and tension-type headache …
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
T Aoki, R Suzuki, Y Kuwatsuka, S Kako… - Blood, The Journal …, 2015 - ashpublications.org
We sought to clarify the role of high-dose chemotherapy followed by autologous
hematopoietic stem cell transplantation (auto-HSCT) and allogeneic hematopoietic stem cell …
hematopoietic stem cell transplantation (auto-HSCT) and allogeneic hematopoietic stem cell …
Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells
N Fukushima, Y Minami, S Kakiuchi… - Cancer …, 2016 - Wiley Online Library
Aberrant activation of the Hedgehog signaling pathway has been implicated in the
maintenance of leukemia stem cell populations in several model systems. PF‐04449913 (PF …
maintenance of leukemia stem cell populations in several model systems. PF‐04449913 (PF …
Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B‐cell lymphoma and suggests patients' survival benefit from rituximab
Y Oki, K Yamamoto, H Kato… - European journal of …, 2008 - Wiley Online Library
Objectives: To evaluate the prognostic value of absolute lymphocyte count (ALC) at
diagnosis in patients with diffuse large B‐cell lymphoma (DLBCL). Methods: In a large …
diagnosis in patients with diffuse large B‐cell lymphoma (DLBCL). Methods: In a large …
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed …
K Shimada, M Yamaguchi, Y Atsuta, K Matsue… - The Lancet …, 2020 - thelancet.com
Background Intravascular large B-cell lymphoma (IVLBCL) is a rare disease for which there
is no available standard treatment. We aimed to ascertain the safety and activity of R-CHOP …
is no available standard treatment. We aimed to ascertain the safety and activity of R-CHOP …
Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a …
E Wada, T Onoue, T Kobayashi, T Handa… - BMJ Open Diabetes …, 2020 - drc.bmj.com
Introduction The present study aimed to evaluate the effects of flash glucose monitoring
(FGM) and conventional self-monitoring of blood glucose (SMBG) on glycemic control in …
(FGM) and conventional self-monitoring of blood glucose (SMBG) on glycemic control in …
Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations
T Yasuda, M Sanada, M Kawazu… - Blood, The Journal …, 2022 - ashpublications.org
The genetic basis of leukemogenesis in adults with B-cell acute lymphoblastic leukemia (B-
ALL) is largely unclear, and its clinical outcome remains unsatisfactory. This study aimed to …
ALL) is largely unclear, and its clinical outcome remains unsatisfactory. This study aimed to …
Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma
Intravascular large B-cell lymphoma (IVLBCL) is a unique type of extranodal lymphoma
characterized by selective growth of tumor cells in small vessels without lymphadenopathy …
characterized by selective growth of tumor cells in small vessels without lymphadenopathy …
[HTML][HTML] Donor lymphocyte infusion for the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a retrospective …
A Takami, S Yano, H Yokoyama, Y Kuwatsuka… - Biology of Blood and …, 2014 - Elsevier
Because the efficacy of donor lymphocyte infusion (DLI) for acute myeloid leukemia (AML)
relapse after allogeneic hematopoietic stem cell transplantation (HSCT) remains uncertain …
relapse after allogeneic hematopoietic stem cell transplantation (HSCT) remains uncertain …
Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t (8; 21) and inv (16) represent different clinical outcomes
Y Kuwatsuka, K Miyamura, R Suzuki… - Blood, The Journal …, 2009 - ashpublications.org
We analyzed 338 adult patients with acute myeloid leukemia (AML) with t (8; 21) and inv
(16) undergoing stem cell transplantation (SCT) who were registered in the Japan Society …
(16) undergoing stem cell transplantation (SCT) who were registered in the Japan Society …